Effect of Panchakarma followed by Lashuna Rasayana in Vatakaphaja Gridhrasi - Case series
DOI:
https://doi.org/10.70066/jahm.v13i7.2191Keywords:
Basti, Chronic low back pain, ESR, Gridhrasi, Hs-CRP, Lashuna RasayanaAbstract
Background: This data discusses the impact of chronic low-back pain (CLBP), sciatica emphasizing their widespread occurrence and debilitating effects on individuals. Vatakphaja Gridhrasi one of the commonest vata vyadhi seen in day to day practice can be treated and further damage can be prevented by the use of Rasayana. It further explores the similarities between sciatica and Ayurvedic condition Vatakphaja Gridhrasi, detailing their symptoms and classifications. Treatment options for sciatica are discussed, which aim to address the underlying imbalances in the body. Clinical Findings: Total of 6 patients were taken for this series who had all the lakshanas of Vatakphaja Gridhrasi and raised ESR and HS-CRP levels were taken for the treatment protocol. Methods: Additionally, the data mentions treatment given, shodhana followed by Lashuna Rasayana 6 capsules were given for the period of 30 days, Lakshanas of Vatakphaja Gridhrasi, Oswestry disability index scale, Roland Morris index scale VAS scale, Clinical examinations along with it HS-CRP and ESR was assessed. Inflammatory markers like Hs-CRP and ESR in relation to pain severity and treatment outcomes, elucidating their roles in indicating acute inflammatory processes and their differing response patterns. Outcome: Lashuna Rasayana 500mg 6capsules was given for 30 days with milk on empty stomach and there was significant reduction in subjective and objective parameters assessed in patients. Conclusion: Overall, this case series provides insights into the complexities of managing, of vatakaphaja gridhrasi with Niruha basti followed by Lashuna Rasayana 6 capsules for 30days. Importance of understanding inflammatory markers in assessing disease progression and effect of Lashuna Rasayana in Vatakphaja Gridhrasi was achieved through subjective and objective parameters assessment during the rasayana usage.
References
Bali Y, Ebnezar J, Venkatesh B, Vijayasarathi R. Efficacy of Agnikarma over the padakanistakam (little toe) and Katibasti in Gridhrasi: A comparative study. International Journal of Ayurveda Research. 2010;1(4):223. DOI: 10.4103/0974-7788.76786
Yadavji Trikamji. Charaka Samhita of Agnivesha, Chikitsasthana, chapter 28,verse no.56, 2nd edition ,Varanasi; Chowkambha Surabharati Prakashan; 2016:619
Moolya R, Shetty S. Synergistic effect of Lashuna Rasayana with Basti Chikitsa (medicated enema therapy) in managing Vata-Kaphaja Gridhrasi (Sciatica): A case report. JAHM [Internet]. 2025May20 [cited 2025Aug.3];13(4):137-42. Available from: https://jahm.co.in/index.php/jahm/article/view/1728
Pinto RZ, Maher CG, Ferreira ML, Ferreira PH, Hancock M, Oliveira VC, McLachlan AJ, Koes B. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012 Feb 13;344:e497. doi: 10.1136/bmj.e497 PMID: 22331277; PMCID: PMC3278391.
Upadhye UN, Patil V. Efficacy of Agnikarma in the management of Gridhrasi (sciatica)- A Scoping review. JAHM [Internet]. 2024Nov.12 [cited 2025Jul.6];12(10):44-55. Available from: https://www.jahm.co.in/index.php/jahm/article/view/1508
Stürmer T, Raum E, Buchner M, Gebhardt K, Schiltenwolf M, Richter W, Brenner H. Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain. Ann Rheum Dis. 2005 Jun;64(6):921-5. doi: 10.1136/ard.2004.027045. PMID: 15897311; PMCID: PMC1755532.
Assasi N, Blackhouse G, Campbell K, Hopkins RB, Levine M, Richter T, Budden A. Comparative Value of Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Testing in Combination Versus Individually for the Diagnosis of Undifferentiated Patients With Suspected Inflammatory Disease or Serious Infection: A Systematic Review and Economic Analysis [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Nov. PMID: 26677507. Doi: https://pubmed.ncbi.nlm.nih.gov/26677507/
Aguilar-Shea AL, Gallardo-Mayo C, Sanz-González R, Paredes I. Sciatica. Management for family physicians. J Family Med Prim Care. 2022 Aug;11(8):4174-4179. doi: https://doi.org/10.4103/jfmpc.jfmpc_1061_21 . Epub 2022 Aug 30. PMID: 36353002; PMCID: PMC9638590..
Wasedar V, Pangam B, Shete S, Belaval V. Complete resolution of lumbar disc sequestration with Ayurveda management: A case report. J Ayurveda Integr Med. 2023 Nov-Dec;14(6):100826. doi: 10.1016/j.jaim.2023.100826. Epub 2023 Nov 25. PMID: 38006747; PMCID: PMC10785238.
Haro H, Kato T, Komori H, Osada M, Shinomiya K. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res. 2002 May;20(3):409-15. doi: 10.1016/S0736-0266(01)00150-4. PMID: 12038611.
Yun HM, Ban JO, Park KR, Lee CK, Jeong HS, Han SB, Hong JT. Potential therapeutic effects of functionally active compounds isolated from garlic. Pharmacol Ther. 2014 May;142(2):183-95. doi: 10.1016/j.pharmthera.2013.12.005. Epub 2013 Dec 11. PMID: 24333688
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Shashidhar A Naik, Vishwanath Wasedar, Poornima B Tukanatti

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.